4//SEC Filing
Stolz Brian M. 4
Accession 0000899243-19-029354
CIK 0001743881other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:05 PM ET
Size
5.6 KB
Accession
0000899243-19-029354
Insider Transaction Report
Form 4
Stolz Brian M.
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2019-12-12+72,696→ 72,696 total→ Common Stock (72,696 underlying)
Footnotes (2)
- [F1]Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date.
- [F2]The units shall vest as to 25% of the units on February 16, 2021, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001524803
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 9:05 PM ET
- Size
- 5.6 KB